FXH First Trust Health Care AlphaDEX Fund
Issuer
First Trust
Inception
May 8, 2007
AUM
$1.2B
Expense ratio
0.61%
Yield
0.54%
Asset class
Sector Equity
Holdings
72
Last price
$137.13
The First Trust Health Care AlphaDEX Fund, an exchange-traded fund (ETF), aims to deliver investment performance that broadly matches the total return (price appreciation and income generation) of the StrataQuant Health Care Index, an equity benchmark. This goal is measured prior to the subtraction of any fees and expenses.
+22.2%
2025-11-13low 104.58 · high 143.632026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| FXH | +4.3% | +4.9% | +21.2% | +23.1% | +14.1% | +3.0% |
| Sector Equity average (81 funds) | -1.2% | -4.5% | +13.3% | +15.0% | +17.1% | +6.1% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$258K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | ZBH Zimmer Biomet Holdings, Inc. | 2.70% |
| 2 | CNC Centene Corporation | 2.53% |
| 3 | UHS Universal Health Services, Inc. (Class B) | 2.52% |
| 4 | CI The Cigna Group | 2.47% |
| 5 | MEDP Medpace Holdings, Inc. | 2.37% |
| 6 | REGN Regeneron Pharmaceuticals, Inc. | 2.26% |
| 7 | GEHC GE HealthCare Technologies Inc. | 2.25% |
| 8 | GMED Globus Medical, Inc. (Class A) | 2.24% |
| 9 | SOLV Solventum Corporation | 2.24% |
| 10 | LLY Eli Lilly and Company | 2.22% |
| 11 | TEM Tempus AI, Inc. (Class A) | 2.16% |
| 12 | EXEL Exelixis, Inc. | 2.16% |
| 13 | ZTS Zoetis Inc. | 2.11% |
| 14 | DXCM DexCom, Inc. | 2.08% |
| 15 | HALO Halozyme Therapeutics, Inc. | 2.05% |
| 16 | THC Tenet Healthcare Corporation | 2.04% |
| 17 | MDT Medtronic Plc | 2.01% |
| 18 | COO The Cooper Companies, Inc. | 1.99% |
| 19 | AMGN Amgen Inc. | 1.98% |
| 20 | UTHR United Therapeutics Corporation | 1.96% |
| 21 | GH Guardant Health, Inc. | 1.93% |
| 22 | JAZZ Jazz Pharmaceuticals Plc | 1.91% |
| 23 | BSX Boston Scientific Corporation | 1.84% |
| 24 | BMY Bristol-Myers Squibb Company | 1.80% |
| 25 | INCY Incyte Corporation | 1.80% |
| 26 | CAI Caris Life Sciences, Inc. | 1.78% |
| 27 | NTRA Natera, Inc. | 1.73% |
| 28 | NBIX Neurocrine Biosciences, Inc. | 1.54% |
| 29 | STE Steris Plc | 1.52% |
| 30 | LH Labcorp Holdings Inc. | 1.51% |
| 31 | VTRS Viatris Inc. | 1.48% |
| 32 | HCA HCA Healthcare, Inc. | 1.48% |
| 33 | ALGN Align Technology, Inc. | 1.48% |
| 34 | EHC Encompass Health Corporation | 1.46% |
| 35 | CORT Corcept Therapeutics Inc. | 1.44% |
| 36 | QGEN QIAGEN N.V. | 1.44% |
| 37 | ASND Ascendis Pharma A/S | 1.42% |
| 38 | ABBV AbbVie Inc. | 1.41% |
| 39 | DGX Quest Diagnostics Incorporated | 1.39% |
| 40 | ELV Elevance Health Inc. | 1.38% |
| 41 | RMD ResMed Inc. | 1.35% |
| 42 | DVA DaVita Inc. | 1.31% |
| 43 | RVMD Revolution Medicines, Inc. | 1.10% |
| 44 | BBIO BridgeBio Pharma, Inc. | 1.08% |
| 45 | BDX Becton, Dickinson and Company | 1.07% |
| 46 | DOCS Doximity, Inc. (Class A) | 1.05% |
| 47 | BIIB Biogen Inc. | 1.00% |
| 48 | ABT Abbott Laboratories | 0.99% |
| 49 | CHE Chemed Corporation | 0.97% |
| 50 | ENSG The Ensign Group, Inc. | 0.97% |
| 51 | NVST Envista Holdings Corporation | 0.96% |
| 52 | HSIC Henry Schein, Inc. | 0.94% |
| 53 | VRTX Vertex Pharmaceuticals Incorporated | 0.93% |
| 54 | PFE Pfizer Inc. | 0.92% |
| 55 | MDGL Madrigal Pharmaceuticals, Inc. | 0.77% |
| 56 | AXSM Axsome Therapeutics, Inc. | 0.72% |
| 57 | ARWR Arrowhead Pharmaceuticals, Inc. | 0.67% |
| 58 | IDXX IDEXX Laboratories, Inc. | 0.56% |
| 59 | MDLN Medline Inc. (Class A) | 0.51% |
| 60 | ELAN Elanco Animal Health Incorporated | 0.49% |
| 61 | HUM Humana Inc. | 0.49% |
| 62 | SYK Stryker Corporation | 0.48% |
| 63 | WST West Pharmaceutical Services, Inc. | 0.46% |
| 64 | ISRG Intuitive Surgical, Inc. | 0.46% |
| 65 | UNH UnitedHealth Group Incorporated | 0.46% |
| 66 | VEEV Veeva Systems Inc. (Class A) | 0.44% |
| 67 | TMO Thermo Fisher Scientific Inc. | 0.44% |
| 68 | DHR Danaher Corporation | 0.44% |
| 69 | JNJ Johnson & Johnson | 0.44% |
| 70 | INSM Insmed Incorporated | 0.44% |
| 71 | A Agilent Technologies, Inc. | 0.43% |
| 72 | BIO Bio-Rad Laboratories, Inc. (Class A) | 0.43% |
| 73 | FXH US Dollar | 0.16% |
Sector breakdown
Healthcare100.0%
Country breakdown
United States100.0%
Distributions
| Date | Per unit |
|---|---|
| Sep 24, 2026 | $0.2917 |
| Jun 25, 2026 | $0.1183 |
| Mar 26, 2026 | $0.1858 |
| Dec 12, 2025 | $0.1399 |
| Sep 25, 2025 | $0.5821 |
| Jun 26, 2025 | $0.0616 |
| Mar 27, 2025 | $0.0669 |
| Dec 13, 2024 | $0.0899 |
| Sep 26, 2024 | $0.1263 |
| Jun 27, 2024 | $0.1090 |
| Mar 21, 2024 | $0.1062 |
| Dec 22, 2023 | $0.1304 |
| Sep 22, 2023 | $0.0332 |
| Jun 27, 2023 | $0.0377 |
| Mar 24, 2023 | $0.0438 |
| Dec 23, 2022 | $0.1214 |
| Sep 23, 2022 | $0.1007 |
| Jun 21, 2013 | $0.0050 |
| Dec 21, 2012 | $0.1240 |
| Jun 21, 2012 | $0.0170 |
| Jun 21, 2011 | $0.0320 |
| Dec 21, 2010 | $0.0290 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in FXH in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error